UPDATE: JP Morgan Downgrades Mead Johnson Nutrition to Neutral on Top-Line Concerns
JP Morgan downgraded Mead Johnson Nutrition Company (NYSE: MJN) from Overweight to Neutral and lowered the price target from $71.00 to $68.00.
JP Morgan said, "With the stock trading at 20.5x NTM P/E and 13.2x EV/EBITDA, valuation metrics are near the high end of all consumer staples despite a great deal of uncertainty around near-term fundamentals. We are increasingly concerned about the top-line potential in 2013, and we think margins will get hit in 2H13 by higher dairy costs. We still consider MJN a fundamentally strong company but would look for a better entry point before buying the shares."
Mead Johnson Nutrition closed at $66.96 on Wednesday.
Latest Ratings for MJN
|Mar 2017||Credit Suisse||Downgrades||Outperform||Neutral|
|Feb 2017||BMO Capital||Downgrades||Outperform||Market Perform|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.